PANCREATOGENOUS DIABETES

This adverse event was reported 65 times

PANCREATOGENOUS DIABETES is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NIVOLUMAB AND HYALURONIDASE-NVHY 1 0.0074
1 FENOFIBRIC ACID 1 0.0013
2 SENNOSIDES A AND B 2 0.0012
3 MINERAL OIL 1 0.0007
4 INSULIN DEGLUDEC AND LIRAGLUTIDE 1 0.0006
5 NALDEMEDINE 1 0.0006
6 INSULIN LISPRO-AABC 1 0.0005
7 PYRIDOXINE HYDROCHLORIDE 1 0.0004
8 NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) 5 0.0003
9 VONOPRAZAN FUMARATE 2 0.0002
See all drugs enriched for association with PANCREATOGENOUS DIABETES